Cargando…
Use of GP73 in the diagnosis of non-alcoholic steatohepatitis and the staging of hepatic fibrosis
OBJECTIVE: To evaluate the utility of Golgi protein 73 (GP73) in the diagnosis of non-alcoholic steatohepatitis (NASH) and hepatic fibrosis (HF) staging. METHODS: Ninety-one patients with non-alcoholic fatty liver disease (NAFLD) were allocated to NAFL (n = 46) and NASH (n = 45) groups according to...
Autores principales: | Li, Yadi, Yang, Yan, Li, Yufang, Zhang, Ping, Ge, Gaiying, Jin, Jing, Du, Ting, Ma, Maiyan, Na, Li, Ding, Lu, Sheng, Huiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593324/ https://www.ncbi.nlm.nih.gov/pubmed/34772312 http://dx.doi.org/10.1177/03000605211055378 |
Ejemplares similares
-
Value of controlled attenuation parameter in fibrosis prediction in nonalcoholic steatohepatitis
por: Lee, Jung Il, et al.
Publicado: (2019) -
Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B
por: Hu, Yan-Chao, et al.
Publicado: (2017) -
Chronic hepatitis B, nonalcoholic steatohepatitis and physical fitness of military males: CHIEF study
por: Chen, Yu-Jung, et al.
Publicado: (2017) -
GP73 regulates Hepatic Steatosis by enhancing SCAP-SREBPs interaction
por: Yang, Xiaoli, et al.
Publicado: (2017) -
GP73-mediated secretion of AFP and GP73 promotes proliferation and metastasis of hepatocellular carcinoma cells
por: Liu, Yujuan, et al.
Publicado: (2021)